03:41 AM EDT, 10/28/2026 (MT Newswires) -- GSK (GSK.L) logged 1.54 billion pounds sterling in profit attributable to shareholders for the third quarter, compared with 2.01 billion pounds a year ago. EPS moved to 0.379 pound from 0.491 pound year over year, a Wednesday filing showed. For the three months ended Sept. 30, turnover was 8.89 billion pounds versus 8.55 billion pounds previously, the UK-listed drugmaker added. Analysts polled by FactSet were expecting 8.86 billion pounds in sales, 2.03 billion pounds in net income, and 0.5 pound in EPS. Meanwhile, the board declared a third interim dividend of 0.17 pound per share, payable on Jan. 7, 2027, to shareholders on record Nov. 13, 2026. It paid 0.16 pound per share in the year-ago period. The company reconfirmed its earlier growth guidance, including turnover at the upper half of the 3% to 5% range, core operating profit at the upper half of the 7% to 9% range, and core EPS at the lower half of the 7% to 9% range, at constant exchange rates, for 2026. GSK expects to pay a dividend of 0.70 pound per share for 2026.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.